A nurse is caring for a client who is receiving terbutaline to treat preterm labor. Which of the following findings should the nurse identify as a potential adverse effect of this medication?

A. Administer 500 ml lactated Ringer's IV bolus:

This choice may be relevant in the context of postpartum hemorrhage, but the first step should be to assess the client's status, including urinary output. Administering fluids without a clear assessment may not address the underlying cause.

B. Replace the surgical dressing:

Vaginal bleeding after a cesarean birth is unlikely to be addressed by replacing the surgical dressing. This action may not address the root cause of the bleeding, which needs further assessment.

C. Apply an ice pack to the incision site:

Using an ice pack is not the appropriate intervention for postpartum bleeding. Ice is typically used for pain and swelling, not for controlling bleeding.

D. Evaluate urinary output:

This is the correct choice. Evaluating urinary output is crucial to assess the client's overall fluid status and kidney perfusion. In the context of postpartum bleeding, it helps determine if there is hypovolemia or other issues contributing to the bleeding. Adequate urinary output is a positive sign of organ perfusion.

A. This infection requires that airborne precautions be initiated for the newborn: Cytomegalovirus (CMV) is not typically transmitted through the airborne route. It is primarily spread through direct contact with infected bodily fluids, such as saliva, urine, blood, and genital secretions.

B. Transmission can occur via the saliva and urine of the newborn: CMV can be transmitted through close contact with infected bodily fluids, including saliva and urine. Newborns can contract CMV during delivery or through contact with their mother's infected bodily fluids.

C. Lesions are visible on the mother’s genitalia: Unlike some other viral infections, CMV does not typically present with visible lesions on the genitalia. CMV infection may be asymptomatic or cause mild symptoms in healthy individuals.

D. Mothers will receive prophylactic treatment with acyclovir prior to delivery: Acyclovir is an antiviral medication used to treat herpes simplex virus (HSV) infections, not CMV. There is no standard antiviral prophylactic treatment for CMV in pregnancy.